IRIS
BERGAMINI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.702
AS - Asia 2.439
NA - Nord America 2.085
SA - Sud America 493
AF - Africa 41
OC - Oceania 12
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.774
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.999
RO - Romania 1.749
RU - Federazione Russa 1.699
SG - Singapore 908
CN - Cina 770
IT - Italia 437
BR - Brasile 408
HK - Hong Kong 247
SE - Svezia 234
VN - Vietnam 231
FR - Francia 121
DE - Germania 117
GB - Regno Unito 94
IN - India 79
NL - Olanda 53
FI - Finlandia 50
AR - Argentina 41
CA - Canada 39
MX - Messico 39
ES - Italia 38
JP - Giappone 34
PL - Polonia 31
TR - Turchia 29
ID - Indonesia 23
AT - Austria 20
ZA - Sudafrica 20
IE - Irlanda 18
BD - Bangladesh 16
IQ - Iraq 15
PK - Pakistan 14
LT - Lituania 11
EC - Ecuador 10
BE - Belgio 9
CO - Colombia 8
JO - Giordania 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
CL - Cile 6
IL - Israele 6
MA - Marocco 6
PH - Filippine 6
QA - Qatar 6
SA - Arabia Saudita 6
UA - Ucraina 6
MY - Malesia 5
PE - Perù 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KR - Corea 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
CH - Svizzera 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
JM - Giamaica 2
KW - Kuwait 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
TJ - Tagikistan 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.774
Salva come PNG Salva come JPEG
Città #
Singapore 460
Dallas 413
Moscow 357
Ashburn 299
Hong Kong 246
San Jose 222
Beijing 149
Shanghai 138
Milan 136
New York 124
Hefei 94
Lauterbourg 84
Ho Chi Minh City 83
Los Angeles 71
Hanoi 57
Lawrence 46
Munich 46
Princeton 46
São Paulo 44
Boardman 41
Orem 39
Chennai 29
Warsaw 28
Tokyo 27
Turku 26
Denver 25
Santa Clara 25
Vaprio d'Adda 25
Bergamo 24
Nuremberg 24
London 22
Rome 21
Boston 20
The Dalles 20
Amsterdam 19
Council Bluffs 19
Manchester 19
Dublin 18
Brooklyn 17
Helsinki 17
Mexico City 17
Montreal 17
Brescia 16
Frankfurt am Main 16
Haiphong 16
Poplar 16
Seattle 16
Stockholm 16
Columbus 15
Johannesburg 15
Atlanta 14
Houston 14
Rio de Janeiro 14
St Petersburg 13
Phoenix 11
Toronto 11
Cesano Boscone 10
Pune 10
Rho 10
Ankara 9
Gatchina 9
Guangzhou 9
Mumbai 9
Querétaro 9
Shenzhen 9
Valencia 9
Belo Horizonte 8
Chicago 8
Florence 8
Istanbul 8
New Delhi 8
Paris 8
Tianjin 8
Vienna 8
Brussels 7
Lappeenranta 7
San Francisco 7
Tashkent 7
Xi'an 7
Biên Hòa 6
Brasília 6
Campinas 6
Charlotte 6
Da Nang 6
Doha 6
Falkenstein 6
Fortaleza 6
Turin 6
Amman 5
Baghdad 5
Curitiba 5
Dalmine 5
Kuala Lumpur 5
Lima 5
Philadelphia 5
Porto Alegre 5
Ribeirão Preto 5
Seriate 5
Shijiazhuang 5
Yekaterinburg 5
Totale 4.163
Salva come PNG Salva come JPEG
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 388
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 365
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 358
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 351
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 345
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 327
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 224
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 217
Additional value of uterine artery Doppler pulsatility index for ultrasound diagnosis of placental site trophoblastic tumor: prospective cohort study 211
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 179
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 169
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 142
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 138
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 133
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 129
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 128
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 127
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 125
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 124
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 120
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 120
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 118
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 114
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 112
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 109
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 107
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group 106
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 105
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 104
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 101
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 98
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 96
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 96
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 94
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 94
Psychological aspects and fertility issues of GTD 94
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 89
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 88
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 88
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 87
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 86
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 85
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 82
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 80
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 80
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 80
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 79
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 77
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 76
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 76
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 75
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 75
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 74
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 73
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 73
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 71
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 71
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 70
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 69
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 68
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 67
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 66
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 66
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 65
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 65
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 64
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 63
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 63
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 63
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 63
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 62
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 61
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 59
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 58
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 56
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 55
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 54
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 54
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 54
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 54
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 53
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 52
Ovarian endometrioma: what the patient needs 52
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 52
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 51
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 51
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 51
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 50
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 50
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 50
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 49
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 49
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 47
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 47
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 47
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 47
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 46
Fertility preservation in women with cervical cancer 43
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 38
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 32
Totale 10.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20253.377 141 35 64 51 89 130 1.955 162 259 158 139 194
2025/20265.445 455 335 511 764 520 191 541 440 1.466 222 0 0
Totale 10.037